42C.SI · IX Biopharma
Singapore · RS rating 96 · As of 2026-10-14
| Price | 0.55 SGD |
|---|---|
| 1-day change | +1.9% |
| RS rating (overall / 1M / 3M / 12M) | 96 / 63 / 96 / 98 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 51 / 54 / 36 |
| Industry group (rank) | Medical-Generic Drugs (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +31.5% |
| Distance from 52-week high | +12.8% |
| Market cap (USD) | $451.4M |